Antimicrobial Agents and Chemotherapy · 2005 · 83 citations · 23 references
PharmacyPharmacokineticsPharmacologyAntimicrobial PharmacologyAntimicrobial PharmacotherapyPharmacokinetic ModelingAntimicrobial Penetration Into TissuesPermeability AssessmentPharmacokinetics Of AntimicrobialsAntibiotic Penetration Into TissueAverage Steady-state ConcentrationConcentration - Time Profile AnalysisConcentration-time Profile SimulationEscherichia ColiFosfomycin TherapyPlasma Concentration - Time ProfileTissue Penetration Of Antimicrobials
The present study was performed to evaluate the ability of fosfomycin, a broad-spectrum antibiotic, to penetrate into abscess fluid. Twelve patients scheduled for surgical or computer tomography-guided abscess drainage received a single intravenous dose of 8 g of fosfomycin. The fosfomycin concentrations in plasma over time and in pus upon drainage were determined. A pharmacokinetic model was developed to estimate the concentration-time profile of fosfomycin in pus. Individual fosfomycin concentrations in abscess fluid at drainage varied substantially, ranging from below the limit of detection up to 168 mg/liter. The fosfomycin concentrations in pus of the study population correlated neither with plasma levels nor with the individual ratios of abscess surface area to volume. This finding was attributed to highly variable abscess permeability. The average concentration in pus was calculated to be 182 +/- 64 mg/liter at steady state, exceeding the MIC(50/90)s of several bacterial species which are commonly involved in abscess formation, such as streptococci, staphylococci, and Escherichia coli. Hereby, the exceptionally long mean half-life of fosfomycin of 32 +/- 39 h in abscess fluid may favor its antimicrobial effect because fosfomycin exerts time-dependent killing. After an initial loading dose of 10 to 12 g, fosfomycin should be administered at doses of 8 g three times per day to reach sufficient concentrations in abscess fluid and plasma. Applying this dosing regimen, fosfomycin levels in abscess fluid are expected to be effective after multiple doses in most patients.
23
World Medical Association Declaration of Helsinki
Not Available Not Available · JAMA · 2000 · 2.4K citations
Medical vs Surgical Management of Spinal Epidural Abscess
Farhan Siddiq, Ashish Chowfin, Robert R. Tight et al. · Archives of Internal Medicine · 2004 · 175 citations
Bettina Pfausler, Heinrich Spiss, Ronny Beer et al. · Journal of neurosurgery · 2003 · 151 citations